Immuneel Therapeutics presents early data from India for Varnimcabtagene autoleucel at ASH Annual… EP News Bureau Dec 22, 2022 Seventy seven overall responses at day 90 in patients with multi-line treated leukemia and lymphoma who received Varnimcabtagene…
Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health… EP News Bureau Jan 18, 2021 The facility will currently focus on autologous cell therapies including CAR-T cell therapy for lymphomas and leukaemias
Immuneel, HCB and IDIBAPS enter into a collaboration and licensing agreement for CAR T cell therapy EP News Bureau Oct 13, 2020 Immuneel acquires exclusive license to CD19 CAR T product for the potential treatment of B cell malignancies for India
